The Keytruda wonder drug for big pharma shareholders
Keytruda is part of a new class of drugs that supposedly helps the immune system fight cancer. Experts estimate that the market could be worth tens of billions of dollars a year.
And it appears that the FDA may have gotten caught up in the excitement over that cash grab, because they sure as heck couldn't have been caught up in the science.
While Keytruda was a dud for three out of every four patients who tried it, it left many of them with plenty of bad memories. I'm talking about constipation, skin rashes, joint pain and other side effects that I guess we'll just figure out as we go.
Keytruda is bound to make more Merck shareholders happy than it is patients. And before you or a loved one gets the guinea-pig treatment with Big Pharma's latest wonder drug, ask Merck to do something the FDA never had the backbone to request.
Some REAL research.
Never experimenting with your health,
William Campbell Douglass II, M.D.
-------------------------------------------------------------------------------------
My friendly public service warning for all free will human beings
Will your doctor protect you ?
No comments:
Post a Comment